CD40LG and bacterial infectious disease: Our key in vivo findings are that IgM‐IVIg enhances the clearance of bacterial infection and reduces lung pathology and inflammatory cytokines levels alongside preventing a loss of systemic B‐cell populations and antibody levels following experimental stroke.